Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Hum Pathol ; 111: 92-97, 2021 05.
Article in English | MEDLINE | ID: mdl-33722650

ABSTRACT

Nonmass enhancement (NME) on breast magnetic resonance imaging (MRI) is defined as an area whose internal enhancement characteristics can be distinguished from the normal surrounding breast parenchyma, without an associated mass in the Breast Imaging Reporting and Data System lexicon. In this study, we evaluated the pathologic correlates of NME lesions of the breast identified on MRI at our institution, including the frequency of atypical or malignant lesions in the core needle biopsies (CNBs), performed after such a radiologic finding. A retrospective study was performed on all CNBs performed for NME on breast MRI between 2010 and 2019. A total of 443 biopsies from 411 patients were identified, comprising 5.5% of all CNBs over the study period. The pathologic diagnoses were benign in the majority of the biopsies (68.0%), whereas 11.5% and 20.5% of the cases were atypical and malignant lesions, respectively. Of the malignant cases, 69.2% were ductal carcinoma in situ (DCIS) and 30.8% were invasive carcinomas. The most common invasive cancer was invasive ductal carcinoma (50%), followed by invasive lobular carcinoma (39.3%). NME identified on breast MRI carried a significant (32%) risk of atypia and malignancy in our cohort, which confirms that biopsy evaluation of these lesions is warranted. DCIS was the most commonly identified malignancy. Notably, among invasive cancers, invasive lobular carcinoma was identified at a substantially higher frequency that would be expected for that histotype.


Subject(s)
Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/pathology , Carcinoma, Intraductal, Noninfiltrating/pathology , Carcinoma, Lobular/pathology , Adult , Aged , Aged, 80 and over , Biopsy, Large-Core Needle , Breast Neoplasms/diagnosis , Carcinoma, Ductal, Breast/diagnosis , Carcinoma, Intraductal, Noninfiltrating/diagnosis , Carcinoma, Lobular/diagnosis , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Retrospective Studies
2.
Allergy Asthma Proc ; 38(4): 317-321, 2017 Jul 01.
Article in English | MEDLINE | ID: mdl-28668112

ABSTRACT

A case of autoimmune lymphoproliferative syndrome (ALPS) was presented, followed by a discussion of the clinical characteristics, pathophysiology, diagnosis, and management of this disease. Clinical pearls and pitfalls are emphasized for the use of the practicing allergist and the fellow in-training. The diagnosis of ALPS was guided by published criteria. A careful history and workup were needed to exclude other possible etiologies for the patient's symptoms and physical findings. ALPS often carries significant morbidity and is best managed through a multidisciplinary approach.


Subject(s)
Autoimmune Diseases/diagnosis , Autoimmune Lymphoproliferative Syndrome/diagnosis , Autoimmune Diseases/epidemiology , Autoimmune Lymphoproliferative Syndrome/genetics , Autoimmune Lymphoproliferative Syndrome/immunology , Autoimmune Lymphoproliferative Syndrome/therapy , DNA Mutational Analysis , Diagnosis, Differential , Genetic Predisposition to Disease , Humans , Male , Mutation , Phenotype , Predictive Value of Tests , Young Adult , fas Receptor/genetics
3.
ACG Case Rep J ; 2(2): 113-5, 2015 Jan.
Article in English | MEDLINE | ID: mdl-26157931

ABSTRACT

We present a case of a large, sterile, subhepatic abdominal wall abscess secondary to foreign body reaction to dropped gallstones during laparoscopic cholecystectomy performed 10 years ago. Dropped gallstones are common complications of laparoscopic cholecystectomy, but they rarely result in abscess formation. When abscesses do occur, they may present a few months to a few years after surgery. It is important to recognize dropped gallstones as an etiology for subhepatic abscess in patients with history of laparoscopic cholecystectomy.

4.
J Biomech ; 46(3): 498-505, 2013 Feb 01.
Article in English | MEDLINE | ID: mdl-23159096

ABSTRACT

Tendinopathy is a widespread and disabling condition characterized by collagen fiber disruption and accumulation of a glycosaminoglycan-rich chondroid matrix. Recent clinical reports have illustrated the potential of mechanical loading (exercise) therapies to successfully treat chronic tendinopathies. We have developed a new murine tendinopathy model which requires a single injection of TGF-ß1 into the Achilles tendon midsubstance followed by normal cage activity for 2 weeks. At this time, tendon maximum stress showed a dramatic (66%) reduction relative to that of normal controls and this persisted at four weeks. Loss of material properties was accompanied by abundant chondroid cells within the tendon (closely resembling the changes observed in human samples obtained intra-operatively) and increased expression of Acan, Col1a1, Col2a1, Col3a1, Fn1 and Mmp3. Mice subjected to two weeks of daily treadmill exercise following TGF-ß1 injection showed a similar reduction in tendon material properties as the caged group. However, in mice subjected to 4 weeks of treadmill exercise, tendon maximum stress values were similar to those of naive controls. Tendons from the mice exercised for 4 weeks showed essentially no chondroid cells and the expression of Acan, Col1a1, Col2a1, Col3a1, and Mmp3 was significantly reduced relative to the 4-week cage group. This technically simple murine tendinopathy model is highly amenable to detailed mechanistic and translational studies of the biomechanical and cell biological pathways, that could be targeted to enhance healing of tendinopathy.


Subject(s)
Exercise Therapy , Tendinopathy , Animals , Disease Models, Animal , Extracellular Matrix Proteins/biosynthesis , Gene Expression Regulation/drug effects , Humans , Male , Mice , Tendinopathy/metabolism , Tendinopathy/pathology , Tendinopathy/physiopathology , Tendinopathy/therapy , Time Factors , Transforming Growth Factor beta1/pharmacology , Weight-Bearing
5.
Case Rep Transplant ; 2012: 952359, 2012.
Article in English | MEDLINE | ID: mdl-23259146

ABSTRACT

Posttransplant lymphoproliferative disorders (PTLDs) comprise a wide spectrum of hematologic malignancies that are found increasingly in orthotopic liver transplant (OLT) patients given the rising frequency of these surgeries and their long-term success. PTLDs are highly correlated with both the Epstein-Barr virus (EBV) infection and the degree of immunosuppression involved. Herein is reported a case of a 53-year-old male with successfully treated hepatitis C virus genotype 4 and hepatocellular carcinoma who underwent OLT and developed symptoms of weakness and poor appetite 4 years later while on tacrolimus 3 mg b.i.d. with historically very low plasma levels. He was found to be anemic and colonoscopy revealed a 4.5 cm cecal diffuse large B-cell lymphoma (DLBCL). Further workup revealed mesenteric lymph node enlargement consistent and nodal DLBCL dissemination. He was treated with cyclophosphamide-hydroxyldaunorubicin-oncovin-prednisone-rituximab (CHOP-R) chemotherapy and his tacrolimus dose was lowered. Additionally, he manifested PTLD-associated cryoglobulinemia leading to acute kidney injury. After a prolonged hospitalization he was discharged with close followup.

6.
J Biol Chem ; 287(15): 12230-40, 2012 Apr 06.
Article in English | MEDLINE | ID: mdl-22351765

ABSTRACT

During development, Dlx3 is expressed in ectodermal appendages such as hair and teeth. Thus far, the evidence that Dlx3 plays a crucial role in tooth development comes from reports showing that autosomal dominant mutations in DLX3 result in severe enamel and dentin defects leading to abscesses and infections. However, the normal function of DLX3 in odontogenesis remains unknown. Here, we use a mouse model to demonstrate that the absence of Dlx3 in the neural crest results in major impairment of odontoblast differentiation and dentin production. Mutant mice develop brittle teeth with hypoplastic dentin and molars with an enlarged pulp chamber and underdeveloped roots. Using this mouse model, we found that dentin sialophosphoprotein (Dspp), a major component of the dentin matrix, is strongly down-regulated in odontoblasts lacking Dlx3. Using ChIP-seq, we further demonstrate the direct binding of Dlx3 to the Dspp promoter in vivo. Luciferase reporter assays determined that Dlx3 positively regulates Dspp expression. This establishes a regulatory pathway where the transcription factor Dlx3 is essential in dentin formation by directly regulating a crucial matrix protein.


Subject(s)
Dentin/pathology , Extracellular Matrix Proteins/genetics , Gene Deletion , Gene Expression Regulation, Developmental , Homeodomain Proteins/genetics , Neural Crest/metabolism , Phosphoproteins/genetics , Sialoglycoproteins/genetics , Transcription Factors/genetics , Ameloblasts/metabolism , Ameloblasts/physiology , Animals , Base Sequence , Cell Differentiation , Cell Line , Dental Enamel/growth & development , Dental Enamel/metabolism , Dentin/growth & development , Dentin/metabolism , Dentin Dysplasia/genetics , Dentin Dysplasia/pathology , Down-Regulation , Extracellular Matrix Proteins/metabolism , Genes, Reporter , Homeodomain Proteins/metabolism , Luciferases, Renilla/biosynthesis , Luciferases, Renilla/genetics , Mandible/metabolism , Mesoderm/metabolism , Mice , Mice, Transgenic , Molecular Sequence Data , Odontoblasts/metabolism , Odontoblasts/physiology , Phosphoproteins/metabolism , Promoter Regions, Genetic , Protein Binding , Sialoglycoproteins/metabolism , Tooth/growth & development , Tooth/metabolism , Tooth/pathology , Transcription Factors/metabolism
7.
Biomaterials ; 33(5): 1618-26, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22130565

ABSTRACT

Therapeutic strategies following spinal cord injury must address the multiple barriers that limit regeneration. Multiple channel bridges have been developed that stabilize the injury following implantation and provide physical guidance for regenerating axons. These bridges have now been employed as a vehicle for localized delivery of lentivirus. Implantation of lentivirus loaded multiple channel bridges produced transgene expression that persisted for at least 4 weeks. Expression was maximal at the implant at the earliest time point, and decreased with increasing time of implantation, as well as rostral and caudal to the bridge. Immunohistochemical staining indicated transduction of macrophages, Schwann cells, fibroblasts, and astrocytes within the bridge and adjacent tissue. Subsequently, the delivery of lentivirus encoding the neurotrophic factors NT-3 or BDNF significantly increased the extent of axonal growth into the bridge relative to empty scaffolds. In addition to promoting axon growth, the induced expression of neurotrophic factors led to myelination of axons within the channels of the bridge, where the number of myelinated axons was significantly enhanced relative to control. Combining gene delivery with biomaterials to provide physical guidance and create a permissive environment can provide a platform to enhance axonal growth and promote regeneration.


Subject(s)
Gene Transfer Techniques , Lentivirus/genetics , Nerve Growth Factors/genetics , Nerve Growth Factors/pharmacology , Spinal Cord Injuries/therapy , Spinal Cord Regeneration/drug effects , Tissue Scaffolds/chemistry , Animals , Axons/drug effects , Axons/pathology , Brain-Derived Neurotrophic Factor/pharmacology , HEK293 Cells , Humans , Myelin Sheath/drug effects , Myelin Sheath/metabolism , Myelin Sheath/pathology , Neurotrophin 3/pharmacology , Prosthesis Implantation , Rats , Rats, Long-Evans , Spinal Cord/metabolism , Spinal Cord/pathology , Spinal Cord Injuries/pathology , Time Factors , Transduction, Genetic , Transgenes/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...